Calcification MCQs With Answer

Calcification MCQs With Answer — This concise, SEO-focused introduction helps B.Pharm students master calcification concepts relevant to pharmacology, pathology, and clinical pharmacy. Covering mechanisms such as dystrophic and metastatic calcification, calcium-phosphate homeostasis, vascular smooth muscle cell osteogenic transformation, and regulatory inhibitors (pyrophosphate, fetuin-A, matrix Gla protein), these Calcification MCQs With Answer are ideal for exam prep and practical application. Expect questions on diagnostic staining (von Kossa, Alizarin red), imaging, drug-induced calcification (warfarin, calcium supplements), CKD-related mineral bone disorder, and therapeutic strategies like phosphate binders and vitamin K modulation. Clear answers reinforce learning and clinical reasoning. Now let’s test your knowledge with 50 MCQs on this topic.

Q1. What distinguishes dystrophic calcification from metastatic calcification?

  • Occurs in dead or degenerated tissues with normal serum calcium
  • Occurs due to high serum calcium and phosphate levels in normal tissues
  • Always involves bone formation
  • Is reversible with vitamin D

Correct Answer: Occurs in dead or degenerated tissues with normal serum calcium

Q2. Which histochemical stain is commonly used to detect calcium phosphate deposits in tissues?

  • Periodic acid–Schiff (PAS)
  • von Kossa
  • Gram stain
  • Prussian blue

Correct Answer: von Kossa

Q3. Which protein is a key inhibitor of vascular calcification and requires vitamin K–dependent carboxylation?

  • Fetuin-A
  • Matrix Gla protein (MGP)
  • Osteopontin
  • Alkaline phosphatase

Correct Answer: Matrix Gla protein (MGP)

Q4. In chronic kidney disease (CKD), which disturbance most directly promotes metastatic vascular calcification?

  • Hypokalemia
  • Hyperphosphatemia
  • Low parathyroid hormone (PTH)
  • Hypocalciuria

Correct Answer: Hyperphosphatemia

Q5. Which cell type can transdifferentiate into osteoblast-like cells contributing to vascular calcification?

  • Endothelial cells
  • Vascular smooth muscle cells (VSMCs)
  • Neutrophils
  • Macrophages only

Correct Answer: Vascular smooth muscle cells (VSMCs)

Q6. Which serum laboratory finding is most consistent with metastatic calcification?

  • Normal calcium and phosphate
  • Elevated serum calcium and/or phosphate
  • Isolated elevated alkaline phosphatase with normal electrolytes
  • Low serum phosphate only

Correct Answer: Elevated serum calcium and/or phosphate

Q7. Warfarin therapy can accelerate vascular calcification by inhibiting which process?

  • Vitamin D activation in the kidney
  • γ-carboxylation of vitamin K–dependent proteins like MGP
  • Synthesis of fetuin-A in the liver
  • Calcium absorption from the gut

Correct Answer: γ-carboxylation of vitamin K–dependent proteins like MGP

Q8. Which imaging modality is most sensitive for quantifying coronary artery calcification?

  • Plain radiography
  • Non-contrast cardiac CT (Agatston score)
  • Ultrasound
  • Contrast-enhanced MRI

Correct Answer: Non-contrast cardiac CT (Agatston score)

Q9. Alizarin red S staining in tissue sections indicates the presence of which substance?

  • Lipid accumulation
  • Calcium salts
  • Iron deposits
  • Collagen fibers

Correct Answer: Calcium salts

Q10. Elevated alkaline phosphatase (ALP) in the context of calcification typically reflects increased activity of which process?

  • Matrix vesicle mineralization and hydrolysis of pyrophosphate
  • Inhibition of calcium deposition
  • Increased vitamin K levels
  • Decreased osteoblast function

Correct Answer: Matrix vesicle mineralization and hydrolysis of pyrophosphate

Q11. Which of the following is a circulating systemic inhibitor of calcification produced by the liver?

  • Osteocalcin
  • Fetuin-A
  • Bone morphogenetic protein
  • Collagen type I

Correct Answer: Fetuin-A

Q12. Which genetic disorder is associated with accelerated arterial calcification due to defective elastin or connective tissue?

  • Pseudoxanthoma elasticum (PXE)
  • Marfan syndrome
  • Hemophilia A
  • Cystic fibrosis

Correct Answer: Pseudoxanthoma elasticum (PXE)

Q13. Which pharmacologic agent is used in CKD to lower serum phosphate and may reduce vascular calcification risk?

  • Sevelamer
  • Furosemide
  • Vitamin D analogs exclusively
  • Warfarin

Correct Answer: Sevelamer

Q14. Which mechanism best explains cellular nucleation of mineral in calcification?

  • Formation of lipid-rich cores only
  • Release of matrix vesicles that concentrate calcium and phosphate
  • Direct crystallization exclusively in cytoplasm
  • Immune complex deposition

Correct Answer: Release of matrix vesicles that concentrate calcium and phosphate

Q15. Valvular calcification, particularly of the aortic valve, is most closely linked to which pathological process?

  • Infective endocarditis only
  • Atherosclerotic-like inflammation with osteogenic differentiation
  • Congenital viral infection
  • Decreased mechanical stress

Correct Answer: Atherosclerotic-like inflammation with osteogenic differentiation

Q16. In histology, calcified areas often appear basophilic on H&E stain because of deposition of:

  • Lipids
  • Calcium salts
  • Glycogen
  • Melanin

Correct Answer: Calcium salts

Q17. Which laboratory intervention can acutely precipitate metastatic calcification in susceptible patients?

  • Rapid infusion of phosphate binders
  • Excessive calcium and vitamin D administration
  • Administration of bisphosphonates
  • Low-protein diet

Correct Answer: Excessive calcium and vitamin D administration

Q18. Which enzyme promotes calcification by degrading pyrophosphate, a natural inhibitor of mineralization?

  • Alkaline phosphatase (TNAP)
  • Matrix metalloproteinase-9
  • Phospholipase A2
  • Superoxide dismutase

Correct Answer: Alkaline phosphatase (TNAP)

Q19. In tumor pathology, dystrophic calcification commonly occurs in which circumstance?

  • Metastatic bone-forming tumors only
  • Areas of necrosis within tumors regardless of serum calcium
  • Only benign tumors
  • Only in tumors with hypercalcemia

Correct Answer: Areas of necrosis within tumors regardless of serum calcium

Q20. Which treatment strategy targets secondary hyperparathyroidism to reduce vascular calcification in CKD?

  • Loop diuretics
  • Cinacalcet (calcimimetic)
  • Warfarin
  • High-dose calcium supplements

Correct Answer: Cinacalcet (calcimimetic)

Q21. The calcium-phosphate product (Ca x P) is clinically important because values above a threshold increase the risk of:

  • Hypocalcemia
  • Soft tissue and vascular calcification
  • Decreased bone turnover only
  • Hyperkalemia

Correct Answer: Soft tissue and vascular calcification

Q22. Which signaling pathway is implicated in the osteogenic transformation of vascular smooth muscle cells?

  • NF-κB exclusively
  • Bone morphogenetic proteins (BMP) and Runx2 pathways
  • Insulin signaling only
  • Notch signaling exclusively

Correct Answer: Bone morphogenetic proteins (BMP) and Runx2 pathways

Q23. Which clinical condition is least likely to be associated with metastatic calcification?

  • Primary hyperparathyroidism
  • Chronic kidney disease with hyperphosphatemia
  • Localized tissue necrosis after trauma
  • Excess vitamin D intake

Correct Answer: Localized tissue necrosis after trauma

Q24. Which phosphate binder would be preferred in a patient with hyperphosphatemia but high risk of vascular calcification due to hypercalcemia?

  • Calcium acetate
  • Sevelamer hydrochloride
  • Calcium carbonate
  • Vitamin D analog

Correct Answer: Sevelamer hydrochloride

Q25. Which clinical test is most useful to monitor progression of calcific aortic stenosis noninvasively?

  • Chest X-ray only
  • Transthoracic echocardiography assessing valve area and gradient
  • Serum calcium measurement
  • Holter monitoring

Correct Answer: Transthoracic echocardiography assessing valve area and gradient

Q26. Which of the following molecules acts as an endogenous inhibitor of hydroxyapatite formation?

  • Pyrophosphate (PPi)
  • Calcium ion
  • Alkaline phosphatase
  • Phosphate ion

Correct Answer: Pyrophosphate (PPi)

Q27. In experimental models, deficiency of which liver-derived protein results in enhanced calcification?

  • Fetuin-A
  • Albumin
  • Transferrin
  • C-reactive protein

Correct Answer: Fetuin-A

Q28. Which drug class has been investigated for potential inhibition of vascular calcification via effects on bone metabolism?

  • Statins only
  • Bisphosphonates
  • Beta-blockers
  • ACE inhibitors

Correct Answer: Bisphosphonates

Q29. Which of the following best describes metastatic pulmonary calcification?

  • Calcification confined to atherosclerotic plaques in pulmonary arteries
  • Calcium deposition in normal lung tissue due to hypercalcemia
  • Calcification only following pulmonary infarction
  • Calcification secondary to chronic bronchitis

Correct Answer: Calcium deposition in normal lung tissue due to hypercalcemia

Q30. Which laboratory marker may be elevated in active calcific processes with bone formation activity?

  • Alkaline phosphatase (bone isoform)
  • Serum potassium
  • C-peptide
  • Amylase

Correct Answer: Alkaline phosphatase (bone isoform)

Q31. Which cellular structure is often the initial site of mineral nucleation during pathological calcification?

  • Matrix vesicles released from cells
  • Nucleus of fibroblasts only
  • Mitochondria exclusively
  • Lysosomes only

Correct Answer: Matrix vesicles released from cells

Q32. Which vitamin deficiency is mechanistically linked to increased vascular calcification due to impaired carboxylation?

  • Vitamin C
  • Vitamin K
  • Vitamin B12
  • Vitamin E

Correct Answer: Vitamin K

Q33. In arterial calcification, which extracellular matrix protein is frequently upregulated and promotes mineralization?

  • Elastin
  • Osteopontin
  • Hemoglobin
  • Albumin

Correct Answer: Osteopontin

Q34. Which of the following is true about soft tissue calcification in chronic kidney disease-mineral bone disorder (CKD-MBD)?

  • Primarily driven by hypoalbuminemia
  • Influenced by disturbed phosphate handling and PTH imbalance
  • Unaffected by dialysis adequacy
  • Prevented solely by calcium supplementation

Correct Answer: Influenced by disturbed phosphate handling and PTH imbalance

Q35. Which signaling molecule is commonly used as a marker of osteogenic differentiation in calcifying vascular cells?

  • Runx2 (Cbfa1)
  • VEGF only
  • TNF-α exclusively
  • Albumin

Correct Answer: Runx2 (Cbfa1)

Q36. Which therapeutic approach directly reduces circulating phosphate without increasing serum calcium?

  • Calcium carbonate binder
  • Sevelamer (non-calcium phosphate binder)
  • Vitamin D analog supplementation
  • High-dose calcium supplementation

Correct Answer: Sevelamer (non-calcium phosphate binder)

Q37. Which condition would most likely produce calcification visible on a plain chest X-ray?

  • Small early atherosclerotic plaque in coronaries
  • Lobar pneumonia without chronic change
  • Healed granulomatous infection (e.g., tuberculosis)
  • Acute bronchitis

Correct Answer: Healed granulomatous infection (e.g., tuberculosis)

Q38. Which laboratory finding differentiates metastatic from dystrophic calcification?

  • Presence of tissue necrosis
  • Elevated serum calcium/phosphate in metastatic calcification
  • Basophilic deposits on H&E in dystrophic only
  • von Kossa negativity in metastatic calcification

Correct Answer: Elevated serum calcium/phosphate in metastatic calcification

Q39. Which therapeutic agent reduces PTH secretion by increasing sensitivity of calcium-sensing receptors in the parathyroid?

  • Cinacalcet
  • Sevelamer
  • Calcitriol only
  • Furosemide

Correct Answer: Cinacalcet

Q40. Which feature on CT imaging indicates chronic vascular calcification rather than acute plaque rupture?

  • Dense, well-demarcated calcific foci within the arterial wall
  • Absence of any calcification
  • High attenuation blood only
  • Diffuse soft tissue swelling without focal calcification

Correct Answer: Dense, well-demarcated calcific foci within the arterial wall

Q41. In drug-induced calcification, which class of drugs has been associated with promoting calcific lesions due to interference with vitamin K–dependent processes?

  • Calcium channel blockers
  • Vitamin K antagonists (e.g., warfarin)
  • ACE inhibitors
  • Statins

Correct Answer: Vitamin K antagonists (e.g., warfarin)

Q42. Which pathological deposit stains black with von Kossa technique due to precipitation of silver salts?

  • Neutral lipids
  • Phosphate associated with calcium
  • Glycogen
  • Melanin pigment

Correct Answer: Phosphate associated with calcium

Q43. Which of the following interventions is most likely to reduce progression of vascular calcification in high-risk CKD patients?

  • Using calcium-based phosphate binders liberally
  • Controlling serum phosphate with non-calcium binders and managing PTH
  • High dietary calcium intake
  • Withholding dialysis

Correct Answer: Controlling serum phosphate with non-calcium binders and managing PTH

Q44. Atherosclerotic plaque calcification is often associated with which plaque characteristic?

  • Thin fibrous cap and increased vulnerability when microcalcifications are present
  • Always complete protection from rupture
  • Absence of inflammatory cells
  • Immediate plaque regression

Correct Answer: Thin fibrous cap and increased vulnerability when microcalcifications are present

Q45. Which molecule when upregulated in vascular tissue can act as a local promoter of calcification by nucleating hydroxyapatite?

  • Osteocalcin
  • Bone sialoprotein
  • Albumin
  • Hemoglobin

Correct Answer: Bone sialoprotein

Q46. In pathology, which description best fits calciphylaxis seen in end-stage renal disease?

  • Painful skin necrosis with small vessel calcification and thrombosis
  • Benign skin calcification without clinical significance
  • Calcification limited to bone surface
  • Superficial fungal infection

Correct Answer: Painful skin necrosis with small vessel calcification and thrombosis

Q47. Which process increases local concentration of phosphate, promoting calcium phosphate precipitation in tissues?

  • Apoptosis of cells releasing phosphate-rich intracellular contents
  • Decreased extracellular phosphate release
  • Enhanced pyrophosphate synthesis only
  • Inhibition of alkaline phosphatase

Correct Answer: Apoptosis of cells releasing phosphate-rich intracellular contents

Q48. Which dietary or supplemental practice can increase risk of metastatic calcification in susceptible individuals?

  • Excessive vitamin D and calcium supplementation
  • High intake of vitamin K–rich foods
  • Low-phosphate diet
  • Balanced calcium-phosphate intake

Correct Answer: Excessive vitamin D and calcium supplementation

Q49. Which laboratory parameter is most useful to evaluate ongoing bone turnover contributing to calcification risk in CKD?

  • Serum albumin
  • Parathyroid hormone (PTH) levels
  • Serum sodium
  • Urine specific gravity

Correct Answer: Parathyroid hormone (PTH) levels

Q50. Which preventive strategy addresses a mechanism-specific approach to reduce vascular calcification progression?

  • Administration of vitamin K to promote MGP carboxylation
  • Start high-dose calcium supplements indiscriminately
  • Long-term vitamin D intoxication
  • Chronic use of vitamin K antagonists without monitoring

Correct Answer: Administration of vitamin K to promote MGP carboxylation

Author

  • G S Sachin
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators